T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured

2 years ago

Cleanroom operator cutting tumor tissue Picture of Cbio cleanroom operator cutting tumor tissue for T-cell therapy production SØBORG, Denmark, April…

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting

2 years ago

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 12 April 2024 – 8AM CET Fagron publishes agenda for 2024 annual shareholders meeting…

Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering

2 years ago

SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized…

UPDATE: Predicine Introduces PredicineCARE™ NGS Kit for Tumor Profiling

2 years ago

HAYWARD, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Predicine, Inc., a leading molecular insights company, announced the release of its…

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

2 years ago

IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a precision diagnostics company,…

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

2 years ago

- Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring…

Longeveron Announces Closing of $5.2 Million Public Offering

2 years ago

MIAMI, April 11, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing…

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer

2 years ago

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET /…

PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission

2 years ago

TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on…

Carmell Announces Successful Closing of $3.0 Million Private Placement

2 years ago

PITTSBURGH, April 11, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health…